NEUROMEDICAL SYSTEMS INC
424B3, 1996-05-16
TESTING LABORATORIES
Previous: GRANT GEOPHYSICAL INC, NT 10-Q, 1996-05-16
Next: VERITAS SOFTWARE CORP, 10-Q, 1996-05-16



                                                                 


                                                Filed pursuant to
                                                   Rule 424(b)(3)
                                           Registration Statement
                                                   No.:  33-97722


Prospectus Supplement No. 5 dated May 16, 1996
(To Prospectus dated December 7, 1995,
 as supplemented on January 17, February 20, April 2, and May
61996)


               SECURITIES AND EXCHANGE COMMISSION
                     WASHINGTON, D.C. 20549
                                
                            FORM 10-Q
                                
          FOR THE QUARTERLY PERIOD ENDED MARCH 31, 1996




<TABLE> <S> <C>

<ARTICLE> 5
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-1996
<PERIOD-END>                               MAR-31-1996
<CASH>                                         105,809
<SECURITIES>                                         0
<RECEIVABLES>                                      878
<ALLOWANCES>                                     (176)
<INVENTORY>                                          0
<CURRENT-ASSETS>                               107,217
<PP&E>                                          20,536
<DEPRECIATION>                                 (7,164)
<TOTAL-ASSETS>                                 120,935
<CURRENT-LIABILITIES>                            6,453
<BONDS>                                          6,457
                                0
                                          0
<COMMON>                                             3
<OTHER-SE>                                     108,022
<TOTAL-LIABILITY-AND-EQUITY>                   120,935
<SALES>                                              0
<TOTAL-REVENUES>                                   651
<CGS>                                                0
<TOTAL-COSTS>                                    8,499
<OTHER-EXPENSES>                                 8,499
<LOSS-PROVISION>                                    62
<INTEREST-EXPENSE>                                 248
<INCOME-PRETAX>                                (6,847)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                            (6,847)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   (6,847)
<EPS-PRIMARY>                                    (.24)
<EPS-DILUTED>                                    (.21)
        

</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission